Document Detail


Genetic association studies in Alzheimer's disease research: challenges and opportunities.
MedLine Citation:
PMID:  14716719     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Genetic association studies have identified important risk factors for Alzheimer's disease and other diseases. However, the ease with which these methods can be applied and the shear number of polymorphisms in the human genome has led to a well-characterized multiple comparison problem-given the number of genetic variants being tested, it is likely that many of the positive findings reported in the literature to date will prove to be false positive findings explained simply by random fluctuation in data and type I error. The disparity of findings in initial positive reports versus subsequent negative replication studies observed in the Alzheimer's disease literature underscores this problem. The problem of a high false positive rate can be addressed in part by using statistical correction for multiple comparisons in larger and statistically more powerful samples and in meta-analyses of smaller samples. National initiatives are now being considered to address this problem by encouraging sharing of genetic material. Of equal concern in planning future initiatives are methodological issues that are the domain of the epidemiologist. In fact, it is possible that disparate findings across case-control studies reported to date may be explained in part by problems in the design, analysis and interpretation of these studies. The involvement of epidemiologists may improve the situation in this regard. For example, population stratification bias, control selection bias and prevalent case bias can be minimized by careful study design and by appropriate statistical analysis. Regarding interpretation of case-control studies, a more careful consideration of the strength of evidence for a given genetic variant may help to temper enthusiasm for, or appropriately qualify, positive findings. Epidemiologists have well-developed causal criteria for this purpose. This paper reviews the current state of case-control studies of genetic variants in Alzheimer's disease from the epidemiological perspective. The problem of multiple comparisons and a high false positive rate is reviewed. The potential for bias in case-control studies of Alzheimer's disease is reviewed by way of example. Future initiatives to promote case-control studies of genetic variants in Alzheimer's disease can only benefit from increased awareness the tools of epidemiology.
Authors:
Steven D Edland; Susan Slager; Matthew Farrer
Related Documents :
7213149 - Abrupt neurological deterioration in children with kearns-sayre syndrome.
23397789 - Apocrine carcinoma of the scalp with aggressive clinical course--a case report and revi...
8116599 - Should we consider a subject's knowledge of the etiologic hypothesis in the analysis of...
10376169 - Prolonged migraine aura without headache arrested by sumatriptan. a case report with fu...
9427489 - Symptoms in patients with giardiasis undergoing upper gastrointestinal endoscopy.
24744569 - Unique paradoxical atlantoaxial dislocation with c1-c2 facet diastases and isolated lig...
3896799 - Ultrasonography of the thyroid. an intracystic carcinoma and mousetyphoid induced absce...
2316769 - Evaluation of active versus passive aids surveillance in oregon.
9522429 - Multi-drug resistant tuberculosis in finland--a forecast.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Statistics in medicine     Volume:  23     ISSN:  0277-6715     ISO Abbreviation:  Stat Med     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2004-01-12     Completed Date:  2004-03-31     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8215016     Medline TA:  Stat Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  169-78     Citation Subset:  IM    
Copyright Information:
Copyright 2004 John Wiley & Sons, Ltd.
Affiliation:
Division of Clinical Epidemiology, Department of Health Science Research, Mayo Clinic and Foundation, Rochester, MN 55905, USA. edland@mayo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alzheimer Disease / genetics*
Case-Control Studies
Humans
Selection Bias
United States
Grant Support
ID/Acronym/Agency:
AG06786/AG/NIA NIH HHS; AG16574/AG/NIA NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine repl...
Next Document:  Family-based association tests for survival and times-to-onset analysis.